Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Terminalia chebula fruit extract has strong anti-aging and antioxidant effects.

Clascoterone cream could be used for other skin conditions affected by hormones.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

AVT is highly conserved and may have antimicrobial properties.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Combining platelet concentrates with stem cells improves regenerative therapies.

Acid can block TRPV3 from outside the cell but boost its function from inside.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

The new drug delivery system effectively targets lung cancer cells.

AcD scaffolds improve tissue repair and regeneration by combining stem cells with a supportive matrix.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

The formulated gel is a promising treatment for alopecia areata.

Valproic acid helps hair follicle stem cells survive better in low oxygen and glucose conditions.

Finasteride may reduce prostate cancer risk.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.